1. Repository of OAI
Ελληνικά   English  

Browsing by Author Pavlidis, N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 174 to 193 of 317 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Near-absolute expression of the bcl-2 protein identifies a subgroup of stage II breast cancer patients with a most favorable outcome. Results of a clinicopathological studyBriasoulis, E.; Agnantis, N. J.; Zagorianakou, P.; Kamina, S.; Gorezi, M.; Pavlidis, N.; Bai, M.24-Nov-2015-
Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysisMauri, D.; Pavlidis, N.; Ioannidis, J. P.24-Nov-2015-
Neuroendocrine carcinoma of unknown primary: a systematic review of the literature and a comparative study with other neuroendocrine tumorsStoyianni, A.; Pentheroudakis, G.; Pavlidis, N.24-Nov-2015-
The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapyPentheroudakis, G.; Malamou-Mitsi, V.; Briasoulis, E.; Damala, K.; Vassou, A.; Vartholomatos, G.; Kolaitis, N.; Pavlidis, N.24-Nov-2015-
New evidence that tamoxifen does not induce osteoporosis: a nuclear activation analysis and absorptiometry studyKalef-Ezra, J.; Glaros, D.; Klouvas, G.; Hatzikonstantinou, J.; Karantanas, A.; Siamopoulos, K. C.; Pavlidis, N.24-Nov-2015-
No increase of plasma malondialdehyde after primary coronary angioplasty for acute myocardial infarctionOlsson, K. A.; Harnek, J.; Ohlin, A. K.; Pavlidis, N.; Thorvinger, B.; Ohlin, H.24-Nov-2015-
Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 casesEconomopoulos, T.; Papageorgiou, S.; Dimopoulos, M. A.; Pavlidis, N.; Tsatalas, C.; Symeonidis, A.; Foudoulakis, A.; Pectasides, D.; Rontogianni, D.; Rizos, E.; Chalkia, P.; Anagnostopoulos, A.; Melachrinou, M.; Papageorgiou, E.; Fountzilas, G.24-Nov-2015-
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome dataMauri, D.; Pentheroudakis, G.; Bafaloukos, D.; Pectasides, D.; Samantas, E.; Efstathiou, E.; Kalofonos, H. P.; Syrigos, K.; Klouvas, G.; Papakostas, P.; Kosmidis, P.; Fountzilas, G.; Pavlidis, N.24-Nov-2015-
Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapyBriasoulis, E.; Pavlidis, N.24-Nov-2015-
A Novel microRNA-Based Test Demonstrate above 90% Accuracy in Classification of Metastatic Tumors from Patients Diagnosed with Carcinoma of Unknown PrimarySanden, M.; Pentheroudakis, G.; St Cyr, B.; Goussia, A.; Lebanony, D.; Stoyianni, K.; Faerman, A.; Fountzilas, G.; Cohen, L.; Malamou-Mitsi, V.; Pavlidis, N.24-Nov-2015-
Old habits die hard: chest radiography for screening purposes in primary careMauri, D.; Kamposioras, K.; Proiskos, A.; Xilomenos, A.; Peponi, C.; Dambrosio, M.; Zacharias, G.; Koukourakis, G.; Pentheroudakis, G.; Pavlidis, N.24-Nov-2015-
Oncology for medical students: a European School of Oncology contribution to undergraduate cancer educationPavlidis, N.; Vermorken, J. B.; Stahel, R.; Bernier, J.; Cervantes, A.; Audisio, R. A.; Pentheroudakis, G.; Costa, A.24-Nov-2015-
Oncology for medical students: a new ESO educational avenuePavlidis, N.; Vermorken, J. B.; Costa, A.24-Nov-2015-
Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary originPavlidis, N.; Briassoulis, E.; Bai, M.; Fountzilas, G.; Agnantis, N.24-Nov-2015-
Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinomaBriasoulis, E.; Rontogianni, D.; Karavasilis, V.; Pavlidis, N.24-Nov-2015-
p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up studyStefanou, D. G.; Nonni, A. V.; Agnantis, N. J.; Athanassiadou, S.; Briassoulis, E.; Pavlidis, N.24-Nov-2015-
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG)Kosmidis, P.; Mylonakis, N.; Skarlos, D.; Samantas, E.; Dimopoulos, M.; Papadimitriou, C.; Kalophonos, C.; Pavlidis, N.; Nikolaidis, C.; Papaconstantinou, C.; Fountzilas, G.24-Nov-2015-
Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized studyKosmidis, P.; Mylonakis, N.; Fountzilas, G.; Samantas, E.; Athanassiadis, A.; Pavlidis, N.; Skarlos, D.24-Nov-2015-
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Pectasides, D.; Kalogera-Fountzila, A.; Skarlos, D.; Kalofonos, H. P.; Papadimitriou, C.; Bafaloukos, D.; Lambropoulos, S.; Papadopoulos, S.; Kourea, H.; Markopoulos, C.; Linardou, H.; Mavroudis, D.; Briasoulis, E.; Pavlidis, N.; Razis, E.; Kosmidis, P.; Gogas, H.24-Nov-2015-
Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: a phase II studyKosmidis, P. A.; Mylonakis, N.; Fountzilas, G.; Samantas, E.; Athanasiadis, A.; Andreopoulou, E.; Pavlidis, N.; Skarlos, D.24-Nov-2015-
Showing results 174 to 193 of 317 < previous   next >